Mitchell I Edelson MD , MBA
Gynecologic Oncology
Chief, Section of Gynecologic Oncology Jefferson Abington Hospital
Join to view full profile
3941 Commerce AveWillow Grove, PA 19090
Phone+1 215-481-6069
Fax+1 215-576-0740
Dr. Edelson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 1995 - 1998
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Obstetrics and Gynecology, 1991 - 1995
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1991
Certifications & Licensure
PA State Medical License 1997 - 2026
NY State Medical License 1993 - 1997
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2014-2016
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2014-2016
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2014-2016
Clinical Trials
- Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial Start of enrollment: 2023 Apr 25
- Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma Start of enrollment: 2022 Nov 16
Publications & Presentations
PubMed
- Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249.Lindsay M Kuroki, Danielle M Enserro, Heather A Lankes, Kyle C Strickland, Rebecca Previs
Gynecologic Oncology. 2026-07-01 - Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial c...Matthew A Powell, Henrik Roed, Lyndsay J Willmott, David Cibula, Destin Black
Gynecologic Oncology. 2026-05-29 - 1 citationsMolecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.Robert L Hollis, Austin Miller, Heather A Lankes, Kwong-Kwok Wong, William Rodgers
Clinical Cancer Research. 2026-02-17
Press Mentions
Planning and Communication Are Key to Mitigate Pelvic Surgery RiskJanuary 13th, 2016
Grant Support
- Sidney Kimmel Cancer Center LAPS Institutional CollaborationTHOMAS JEFFERSON UNIVERSITY2019–2032
Committees
- Advisory Council for Gynecology and Obsterics, American College of Surgeons, Chair 2013 - 2017
- Clinical Practice Committee, Society of Gynecologic Oncology, Chair 2013 - 2015
- Clinical Practice Committee, Society of Gynecologic Oncology, Vice-Chair 2011 - 2013
Professional Memberships
- Fellow
- Fellow
- Fellow
- Society of Gynecologic OncologyMember
- International Gynecologic Cancer SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
